ITRM Iterum Therapeutics plc
Healthcare$0.03-10.98%ClosedMarket Cap: $1.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.34
P/S
7.52
EV/EBITDA
-1.11
DCF Value
$-1.10
FCF Yield
-679.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
-171.3%
Operating Margin
-5202.8%
Net Margin
-6913.1%
ROE
602.4%
ROA
-82.9%
ROIC
-77.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $390.0K | 94.9% | $-7.4M | $-9.0M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-5.5M | $-6.5M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-3.7M | $-4.9M | $— | — |
| Q4 null | $0.00 | NaN% | $-3.7M | $-6.6M | $— | — |
| FY null | $0.00 | -Infinity% | $-18.7M | $-24.8M | $— | — |
| Q3 null | $0.00 | NaN% | $-4.9M | $-6.1M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-4.0M | $-5.0M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-6.2M | $-7.1M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-11.4M | $-12.4M | $— | — |
| FY null | $0.00 | -Infinity% | $-47.5M | $-38.4M | $— | — |
| Q3 2023 | $0.00 | NaN% | $-16.7M | $-3.9M | $-0.30 | — |
| Q2 2023 | $0.00 | NaN% | $-10.8M | $-12.2M | $-0.95 | — |